Expertise in
3
conditions

Jean-marc M. Classe

Rene, FR 
Expertise in
3
conditions
Rene, FR 

Overview

Jean-marc Classe practices practicing medicine in Rene, France.

Mr. Classe is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Breast Cancer, Cervical Cancer, Mastectomy, and Lymphadenectomy.

He is actively involved in clinical research, co-authoring 97 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Rene, France
Other Locations
Nantes, France
Saint Herblain, France
44800 St Herblain, Sete, 44800, France
Loire, France
La Roche, France
Angers, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III Randomized Study Evaluating Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the Treatment of Relapse Ovarian Cancer
A Phase III Randomized Study Evaluating Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the Treatment of Relapse Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 20, 2026
Intervention Type: Procedure, Drug
Study Drug: Hyperthermic Intra-PEritoneal Chemotherapy
Study Phase: Phase 3
Phase III Randomized Clinical Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Considering Two Different Settings: Primary Debulking Surgery (PDS) and Interval Debulking Surgery (IDS)
Phase III Randomized Clinical Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Considering Two Different Settings: Primary Debulking Surgery (PDS) and Interval Debulking Surgery (IDS)
Enrollment Status: Active_not_recruiting
Publish Date: March 16, 2026
Intervention Type: Drug
Study Drug: HIPEC
Study Phase: Phase 3
Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma
Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma
Enrollment Status: Unknown
Publish Date: April 22, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Interest of the Manual Exploration as a Supplement to the Coelioscopy in the Evaluation of the Resectability of Peritoneal Carcinosis
Interest of the Manual Exploration as a Supplement to the Coelioscopy in the Evaluation of the Resectability of Peritoneal Carcinosis
Enrollment Status: Completed
Publish Date: July 09, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Prospective Study Assessing the Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinomatosis of Ovarian Origin, Tubal or Primary Peritoneal, in Chemosensitive Patients Treated by Neoadjuvant Chemotherapy.
Prospective Study Assessing the Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinomatosis of Ovarian Origin, Tubal or Primary Peritoneal, in Chemosensitive Patients Treated by Neoadjuvant Chemotherapy.
Enrollment Status: Completed
Publish Date: July 19, 2017
Intervention Type: Procedure
Study Phase: Phase 2
View 4 Less Clinical Trials

97 Total Publications

[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]].
[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]].
Journal: Bulletin du cancer
Published: April 12, 2026

Frequently Asked Questions about Jean-marc M. Classe

Is Jean-marc M. Classe a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-marc M. Classe is classified as an Distinguished expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-marc M. Classe participate in research or clinical trials?

Yes. Jean-marc M. Classe has published 97 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Jean-marc M. Classe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Classe's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile